Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

New trends data show significant reduction in the incidence of precancerous lesions in young women since advent of vaccine.

rates of cervical intraepithelial neoplasia (CIN) grades 2-3 and adenocarcinoma in situ (AIS), defined as CIN2+, decreased by 79%, and rates of CIN grade 3 and AIS, defined as CIN3+, decreased by ...

Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

There are two types of cervical cancer - squamous cell carcinoma and adenocarcinoma and both are 'named after the type of cell where the cancer started. 'Most cervical cancers (up to 90 per cent ...

Derived from scRNA-seq, SLC26A3 is a potential therapeutic target to improve the efficacy of immunotherapy, as well as a potential diagnostic indicator to reduce post-surgical upstaging, for cervical ...

What should you expect with cervical cancer treatment? Learn more about types of treatment, how well they work, side effects, and more. Almost everyone who’s sexually active gets this infection.

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

Adjuvant CRT did not improve outcomes over adjuvant RT in patients with intermediate-risk, early-stage cervical cancer after radical hysterectomy.

From 2008 to 2022, there were considerable decreases in the rates of cervical intraepithelial neoplasia (CIN) grades 2 to 3 and adenocarcinoma in situ (AIS; collectively CIN2+) and CIN3+ (CIN grade 3 ...

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy ...